Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned an average recommendation of “Reduce” from the seventeen research firms that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a sell rating and twelve have given a hold rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $102.40.
CLX has been the subject of several recent analyst reports. BNP Paribas Exane reduced their price objective on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research report on Monday, July 20th. Royal Bank Of Canada dropped their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Morgan Stanley reduced their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Evercore set a $99.00 target price on Clorox in a research report on Tuesday. Finally, Wells Fargo & Company upped their price objective on shares of Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a report on Tuesday.
Get Our Latest Research Report on Clorox
Clorox News Summary
- Positive Sentiment: Clorox reported fiscal Q4 adjusted earnings of $1.66 per share, ahead of the $1.64 analyst consensus, while revenue of $1.95 billion exceeded the $1.91 billion estimate. The GOJO acquisition contributed meaningfully to sales and helped support the earnings beat. Clorox Q4 Earnings and Revenues Surpass Estimates
- Positive Sentiment: Management projected fiscal 2027 revenue of approximately $7.6 billion to $7.7 billion and adjusted EPS of $5.70 to $6.00. Expected growth is tied to GOJO, market-share recovery, pricing actions and easier comparisons following the enterprise-resource-planning implementation. Clorox forecasts upbeat annual sales as demand improves
- Positive Sentiment: Several analysts raised their price targets after the quarterly results, supporting the immediate market reaction. Clorox also increased its quarterly dividend to $1.25 per share from $1.24, maintaining its appeal to income-oriented investors.
- Neutral Sentiment: JPMorgan lifted its price target from $92 to $95 but retained an “underweight” rating, while Wells Fargo raised its target from $95 to $102 and maintained an “equal weight” rating. Both targets remain below the current share price, signaling limited analyst conviction despite the revisions. JPMorgan raises Clorox price target
- Negative Sentiment: Underlying performance was weaker: quarterly revenue declined 2% year over year, while prior-year EPS was $2.87. Lower volumes, muted category demand, inflation and supply-chain costs are weighing on margins, and consumers continue to trade down to cheaper products. Clorox Q4 results and margin pressures
- Negative Sentiment: Fiscal 2027 EPS guidance is below the roughly $6.23 consensus cited in company coverage, and management expects more than $200 million of inflation-related pressure. This leaves the recovery dependent on GOJO growth, pricing and successful share gains.
Hedge Funds Weigh In On Clorox
A number of large investors have recently made changes to their positions in CLX. Haverford Trust Co boosted its stake in Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank increased its position in shares of Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after buying an additional 100 shares during the period. Golden State Wealth Management LLC lifted its holdings in shares of Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after buying an additional 100 shares in the last quarter. Kestra Private Wealth Services LLC boosted its position in shares of Clorox by 1.8% in the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares during the period. Finally, Johnson Financial Group Inc. grew its stake in Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after acquiring an additional 109 shares in the last quarter. 78.53% of the stock is owned by institutional investors.
Clorox Price Performance
CLX stock opened at $104.26 on Friday. The firm has a market cap of $12.61 billion, a price-to-earnings ratio of 16.93 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company’s fifty day simple moving average is $95.73 and its 200 day simple moving average is $103.52. Clorox has a 12-month low of $84.70 and a 12-month high of $128.90.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping the consensus estimate of $1.64 by $0.02. The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a return on equity of 764.12% and a net margin of 8.74%.The firm’s revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, analysts expect that Clorox will post 6.03 earnings per share for the current year.
Clorox Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.8%. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. Clorox’s payout ratio is currently 80.52%.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
- Five stocks we like better than Clorox
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
